Tetrandrine, an Effective Inhibitor of COVID-19 Main Protease (Mpro); Insights from Molecular Docking and Dynamics Simulations

International Journal of Pharmaceutical Investigation
2023.0

Abstract

Background: Natural products emerged as potential lead molecules in the drug discovery paradigm. During COVID-19 pandemic, researchers explored several natural agents with antiviral activity. The objective of the present study is to predict inhibitors of important COVID-19 targets from a set of potential candidates belonging to natural origin using molecular docking and dynamic simulation. Materials and Methods: Important target, main protease (Mpro) (PDB ID: 6M03) was selected for this purpose. Twenty natural agents were selected for molecular docking (Auto Dock vina 4.2). Molecular dynamic studies were performed using GROMACS. Results and Discussion: Among the selected natural products, tetrandrine, an isoquinoline alkaloid (-8.9 kcal/mol), and etoposide, a podophyllotoxin (-8.4kcal/mol) showed excellent binding affinity compared to remdesivir (-7.1kcal/mol) with Mpro. Further, the stability of the complex formed between Mpro and tetrandrine was confirmed in molecular dynamic studies at 100ns. Conclusion: The present in silico investigation could lead to the development of tetrandrine as a potent COVID-19 inhibitor.

Knowledge Graph

Similar Paper

Tetrandrine, an Effective Inhibitor of COVID-19 Main Protease (Mpro); Insights from Molecular Docking and Dynamics Simulations
International Journal of Pharmaceutical Investigation 2023.0
Potential of Natural Alkaloids From Jadwar (Delphinium denudatum) as Inhibitors Against Main Protease of COVID-19: A Molecular Modeling Approach
Frontiers in Molecular Biosciences 2022.0
Indole alkaloids as potential candidates against COVID-19: an in silico study
Journal of Molecular Modeling 2022.0
Natural Product-Based Screening for Lead Compounds Targeting SARS CoV-2 Mpro
Pharmaceuticals 2023.0
In-silico screening of naturally derived phytochemicals against SARS-CoV Main protease
Environmental Science and Pollution Research 2022.0
Isolation and In Silico Prediction of Potential Drug-like Compounds with a New Dimeric Prenylated Quinolone Alkaloid from Zanthoxylum rhetsa (Roxb.) Root Extracts Targeted against SARS-CoV-2 (Mpro)
Molecules 2022.0
Neoechinulin A as a Promising SARS-CoV-2 Mpro Inhibitor: In Vitro and In Silico Study Showing the Ability of Simulations in Discerning Active from Inactive Enzyme Inhibitors
Marine Drugs 2022.0
Quinoline and Quinazoline Alkaloids against COVID-19: An In Silico Multitarget Approach
Journal of Chemistry 2021.0
A Computational Study of Carbazole Alkaloids from Murraya koenigii as Potential SARS-CoV-2 Main Protease Inhibitors
Applied Biochemistry and Biotechnology 2023.0
Pharmacological hypothesis: TPC2 antagonist tetrandrine as a potential therapeutic agent for COVID‐19
Pharmacology Research & Perspectives 2020.0